AIM2 and head and neck squamous cell carcinoma: Riva et al. [78] have recently investigated the gene expression of AIM2 in 34 HNSCC patients undergoing surgical treatment and the possible correlation between AIM2 levels and HPV infection status, clinical characteristics, and survival [78].